Computational Medicine
Computational Medicine develops and applies computational and AI methods to biomedical signals and neurological data, with the goal of improving diagnosis, treatment, and patient outcomes in neurology, cardiology, and circadian health.
Research impact
Computational Medicine's research has direct impact on clinical practice and patient care. Our work on epilepsy surgery prediction informs treatment decisions for patients with drug-resistant epilepsy, and our open tools and datasets — including the IDEAS database and BrainMoNoCle — are used by researchers internationally. In cardiac monitoring, our novel ECG visualisation methods have been recognised by the MIT Innovators Under 35 Award and the IET Healthcare Technology Awards. Our research is embedded in a wider network of clinical and scientific partnerships.
We collaborate closely with neurology and neurosurgery teams across the UK, and contribute to large international consortia. Our chronobiology work is developing new approaches to monitoring circadian health in real-world settings, with applications in mood disorders, epilepsy, and general wellbeing. The group sits at the intersection of several interdisciplinary specialities — including neuroimaging, signal processing, explainable AI, normative modelling, and human-computer interaction — and maintains active links with Newcastle's clinical neurosciences, the Newcastle Biomedical Research Centre, and the Centre for Transformative Neuroscience.
Key collaborators
Computational Medicine maintains active collaborations with clinical, academic, and industry partners across the UK and internationally. Our collaborative work spans epilepsy surgery, cardiac monitoring, chronobiology, and normative modelling, and includes both research partnerships and patient-facing clinical studies.
- University College London (UCL)
- Chalfont Centre for Epilepsy
- ENIGMA Consortium
- The Christie NHS Foundation Trust
- Cancer Research UK
- Newcastle upon Tyne Hospitals NHS Foundation Trust